Related references
Note: Only part of the references are listed.Correspondence on 'prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis'
Jiyuan Shi et al.
ANNALS OF THE RHEUMATIC DISEASES (2023)
Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis
Shintaro Akiyama et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
How are systematic reviews of prevalence conducted? A methodological study
Celina Borges Migliavaca et al.
BMC MEDICAL RESEARCH METHODOLOGY (2020)
Antipsychotic drug exposure and risk of fracture: a systematic review and meta-analysis of observational studies
Davide Papola et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2018)
Application of the Navigation Guide systematic review methodology to the evidence for developmental and reproductive toxicity of triclosan
Paula I. Johnson et al.
ENVIRONMENT INTERNATIONAL (2016)
Current experience with applying the GRADE approach to public health interventions: an empirical study
Eva A. Rehfuess et al.
BMC PUBLIC HEALTH (2013)
GRADE guidelines: 4. Rating the quality of evidence-study limitations (risk of bias)
Gordon H. Guyatt et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
GRADE:: an emerging consensus on rating quality of evidence and strength of recommendations
Gordon H. Guyatt et al.
BRITISH MEDICAL JOURNAL (2008)
Share Paper
